Double Sided Laser Machining System For Lenses Manufacturing
| Host Organisation: | MSL Med Services Ltd |
| Partner Organisation(s): | PA 1: Laserlabs Ltd |
| Project Budget: | 251.840,00 € |
| IDEK Funding: | 171.528,00 € |
The aim of the project is the development of the Cypriot economy by: increasing the innovativeness of Cypriot enterprises, increase its competitiveness, enhance the role of science in economic development, increasing the share of innovative products of the Cypriot economy in the international market, creating a sustainable and highly specialized jobs and the increased use of information and communication technologies in the economy. The proposal is to implement comprehensive research and development leading to the construction of new, advanced technology of laser micro machining of optical lenses: intra ocular (IOL’s) and contact lenses (c.l.).The innovative technology process will allow to increase the product's quality tremendously, as a result of using lasers for the whole process: cutting and polishing.The current production technology is based on a lathe that cut out half-finished product, which then is processed on simple, manually controlled devices such as polishers and blockers.New technology will significantly improve the efficiency and cost effectiveness of the production process. We expect that the complete manufacturing process can be reduced from 3-4 days to 2-3 minutes. Actual cnc lathe cutting technology doesn't allow the manufacturers to produce the single IOL lens for individual patient. The reason for that is the technical and economical non-effectiveness of actual technology.
The newly invented technology can open the door for another biotechnology products manufactured by use of the lasers. The orthopedics , the cardiology and the neural surgery are one of the most developed surgical specialties which can benefit from implementing the new technology. The possibility of implementing this technology are almost limitless, and it is difficult to estimate, especially in the era of an aging but wealthy society and the continuous increase in demand for highly specialized, safe products for medicine.